Antithrombin III deficiency historical perspective: Difference between revisions

Jump to navigation Jump to search
m (Bot: Adding CME Category::Cardiology)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Antithrombin III deficiency}}
{{Antithrombin III deficiency}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{CMG}}
{{CMG}}; {{AE}}
==Overview==
==Overview==
==Historical Perspective==
==Historical Perspective==
This was first described by Egeberg in 1965.<ref>Egeberg O. ''Inherited antithrombin deficiency causing thrombophilia.'' Thromb Diath Haemorrh 1965;13:516–520. PMID 14347873.</ref>
 
===Discovery===
* There is limited information about the historical perspective of [disease name].
OR
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
 
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
 
===Landmark Events in the Development of Treatment Strategies===
 
===Impact on Cultural History===
 
===Famous Cases===
The following are a few famous cases of [disease name]:


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[CME Category::Cardiology]]


[[Category:Needs content]]
{{WH}}
[[Category:Disease]]
{{WS}}
[[Category:Hematology]]
[[Category:Cardiology]]
[[Category:Pediatrics]]

Revision as of 22:33, 14 July 2020

Antithrombin III deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Antithrombin III deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Antithrombin III deficiency historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Antithrombin III deficiency historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Antithrombin III deficiency historical perspective

CDC on Antithrombin III deficiency historical perspective

Antithrombin III deficiency historical perspective in the news

Blogs on Antithrombin III deficiency historical perspective

Directions to Hospitals Treating Antithrombin III deficiency

Risk calculators and risk factors for Antithrombin III deficiency historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • There is limited information about the historical perspective of [disease name].

OR

  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Landmark Events in the Development of Treatment Strategies

Impact on Cultural History

Famous Cases

The following are a few famous cases of [disease name]:

References

Template:WH Template:WS